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Education and debate
What can mendelian randomisation tell us about
modifiable behavioural and environmental exposures?
George Davey Smith, Shah Ebrahim
Using genetic variants as a proxy for modifiable environmental factors that are associated with
disease can circumvent some of the problems of observational studies
Epidemiologists look for modifiable causes of com-
mon diseases to improve population health. However,
epidemiological studies may identify spurious “causes.”
For example, the epidemiological findings that
hormone replacement therapy protects against coro-
nary heart disease,w1  carotene prevents lung cancer,w2
and vitamin E and vitamin C reduce risk of cardiovas-
cular diseasew3 have all been refuted by randomised
controlled trials and have raised concerns about the
value of epidemiological studies.1 The misleading find-
ings were probably due to confounding by behav-
ioural, physiological, and socioeconomic factors
related both to exposures and to disease end points.2 3
One solution to these problems is mendelian
randomisation. 4 5
What is mendelian randomisation?
Mendelian randomisation is a recent development in
genetic epidemiology 6 7 based on Mendel’s second law
that inheritance of one trait is independent of inherit-
ance of other traits. It uses common genetic
polymorphisms that are known to influence exposure
patterns (such as propensity to drink alcohol) or have
effects equivalent to those produced by modifiable
exposures (such as raised blood cholesterol concentra-
tion). Associations between genetic variants and
outcome are not generally confounded by behavioural
or environmental exposures. This means that observa-
tional studies of genetic variants have similar
properties to intention to treat analyses in randomised
controlled trials (fig 1).
Scope of mendelian randomisation
The simplest way of appreciating the potential of
mendelian randomisation is to consider applications
of the underlying principles. The inferences that
can be drawn from mendelian randomisation
studies depend on the different ways in which genetic
variants can proxy for environmentally modifiable
exposures.
Understanding effects of health related behaviours
In observational studies, alcohol consumption is
related to many known and unknown confounding
factors; ill health may lead people to reduce their
drinking habits, and people often misreport their alco-
hol intake, making interpretation of observed associa-
tions between alcohol consumption and health
outcomes difficult. It is unlikely that the definitive test
of causality—a randomised controlled trial of the long
term effects of alcohol consumption— will ever be car-
ried out. However, genetic variants that influence the
tendency to drink alcohol have been identified,
allowing estimation of the unbiased and uncon-
founded health effects of alcohol.
The enzyme aldehyde dehydrogenase is responsi-
ble for efficient metabolism of alcohol after it has been
oxidised to acetaldehyde. Half of Japanese people are
heterozygous or homozygous for a variant of the alde-
hyde dehydrogenase gene (ALDH2) that is non-
functional, called the null variant, making them unable
to metabolise acetaldehyde efficiently. Peak blood
acetaldehyde concentrations after drinking alcohol
are 18 times higher among people who are
homozygous for the null variant allele and five times
higher among heterozygous people compared with
people with two functioning alleles.w4 Possession of the
null variant allele makes consumption of alcohol
unpleasant; the high acetaldehyde concentrations
induce facial flushing, palpitations, drowsiness, and
other symptoms. People with null variant alleles drink
much less alcohol (table).8 The table also shows the
basic principle of mendelian randomisation—that
genetic variants are not confounded; neither age nor
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smoking, likely confounders of associations between
alcohol consumption and disease, are related to
ALDH2 polymorphisms.
A longstanding debate about the cardioprotective
effect of alcohol may be resolved by examining differ-
ences in risk factors and coronary heart disease events
in people with different ALDH2 variants. Considerable
evidence, including that derived from randomised
controlled trials, suggests that alcohol increases high
density lipoprotein (HDL) cholesterol concen-
trationsw5 w6 (which should protect against coronary
heart disease) and raises blood pressure (which should
mitigate or reverse the protective effect of alcohol).w7 w8
In line with this, the ALDH2 genotype related to
higher alcohol consumption is associated with higher
HDL cholesterol concentrations and hypertension
(table). The difference in HDL cholesterol concentra-
tion between ALDH2 variants is similar to what would
be predicted from the difference in alcohol consump-
tion between ALDH2 variants and the effects of
alcohol consumption on HDL cholesterol observed in
randomised trials.w5 w6 This mathematical similarity
provides strong evidence for the utility of the
mendelian randomisation approach.
Understanding effects of modifying physiological
factors
Genetic variants can influence circulating biochemical
factors such as cholesterol, homocysteine, or fibrino-
gen concentrations. This provides a method for assess-
ing causality in associations observed between these
measures (referred to in genetic epidemiology as inter-
mediate phenotypes) and disease, and thus whether
interventions to modify the intermediate phenotype
could be expected to influence risk of disease. For
example, familial hypercholesterolaemia is a mende-
lian dominant condition in which many rare mutations
of the low density lipoprotein receptor genew9 lead to
high circulating cholesterol concentrationsw10 and pre-
mature coronary heart disease.w11 The inference to be
made from this evidence (now well accepted) is that
high blood cholesterol concentration is an important
cause of coronary heart disease in the general popula-
tion.
In familial hypercholesterolaemia, blood choles-
terol concentrations are about 3.0 mmol/l higher than
in the general population. Thus if we assume a linear
relation between blood cholesterol and risk of
coronary heart disease, the evidence from randomised
trials of statins would predict an increase in coronary
heart disease of around twofold for people with famil-
ial hypercholesterolaemia, whereas fourfold risks are
observed.w11
Have the statin trials underestimated the effect of
long term lowering of cholesterol concentrations? As
atherosclerosis builds up over many years, short term
trials of cholesterol lowering in adulthood would not
mirror the lifetime effects of high blood cholesterol
concentration in familial hypercholesterolaemia. In the
statin trials the relative reduction in mortality from
coronary heart disease increases over time from
randomisation—and thus time with lowered choles-
terol concentrations. This is what would be expected if
raised cholesterol concentrations cause clinical athero-
sclerosis over decades. Furthermore, the strength of
the association increases as the lag period between
cholesterol measurement and mortality increases,w12
indicating that long term rises in cholesterol concen-
tration are the important aetiological factor and that
the longer the reduction in cholesterol, the greater the
benefits.
In mendelian randomisation approaches, genetic
variants are equivalent to lifetime differences in blood
cholesterol and indicate the long term effects of lower
blood cholesterol concentrations on disease. They
therefore generate more realistic estimates of causal
effects that are free from measurement error or short
term fluctuations in cholesterol concentrations, both of
which may dilute the strength of association.
In some circumstances, physiological risk factors
that seem to be targets for intervention may actually be
influenced by the disease process itself—“reverse
causation.” For example, the presence of atherosclero-
sis increases circulating fibrinogen concentrations.
Although fibrinogen concentration predicts risk of
coronary heart disease, a genetic variant associated
with higher concentrations of fibrinogen is not associ-
ated with higher risk of disease.9 This suggests that
reverse causation may generate the association
between fibrinogen and coronary heart disease and,
crucially, that lowering fibrinogen concentrations may
not prevent disease. However, in such situations the
genetic association studies need to be of very large
sample size to provide robust evidence.9
Swinging the lead or toxic jobs?
The potential hazards of sheep dip have prompted
parliamentary questions in Britain and considerable
discussion about the merits of banning organo-
phosphates used in sheep dip.w13 Farmers exposed to
sheep dips containing organophosphates attribute a
variety of chronic symptoms to sheep dip.10 In 1999,
however, a British government committee considered
that the evidence did not support a causal link
between sheep dip and farmers’ symptoms.w14
Randomised trials of exposure to sheep dip would not
be feasible, and as people in studies of organophos-
phate exposure generally know the possible health
problems, it is difficult to conduct valid case-control
studies.
Genetic variants that modify the biological
response to the exposure (in this case variants related
to detoxification of organophosphates10) can indicate
the effects of different levels of exposure. Different
forms of the enzyme paraoxonase have varying ability
to detoxify sheep dip. If organophosphates truly cause
ill health, then people with the genetic variants that are
less efficient would be expected to form a higher pro-
portion of exposed people with symptoms than those
with more efficient variants, and this is what is found.10
Since it is unlikely that the detoxification genotype will
affect a person’s tendency to report symptoms or to
Relation between ALDH2 genotype and various characteristics8
Homozygous
for null variant
Heterozygous
for null variant
Homozygous for
functioning variant
Mean alcohol consumption (ml/day) 5.3 15.1 29.2
Mean age (years) 61.3 61.5 60.6
% smokers 48.5 47.9 47.7
Mean HDL cholesterol concentration
(mmol/l)
1.24 1.35 1.4
% with hypertension 40.6 37.7 46.9
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desire compensation or early retirement, these findings
provide evidence that exposure to sheep dip has a
causal effect on health.
Intrauterine environment and health
Fetal exposures during pregnancy are difficult to
measure but may be modified by parental genotype.
For example, folate deficiency in pregnancy is now
known to be a cause of neural tube defects.w15 w16 A
polymorphism in the gene MTHFR is associated with
metabolic effects equivalent to those seen with lower
folate intake, and in a meta-analysis of case-control
studies of neural tube defects, mothers homozygous
for this variant (TT) had double the risk of having an
infant with a neural tube defect compared with moth-
ers homozygous for the CC variant.11 The relative risk
of a neural tube defect associated with the TT genotype
in the infant was less than that observed for maternal
genotype, and paternal genotype had no effect on risk.
This suggests that the intrauterine environment, influ-
enced by maternal TT genotype operating as a proxy
for lower maternal folate concentrations, rather than
the genotype of the offspring increases the risk of neu-
ral tube defect. The association between maternal
MTHFR genotype and risk of neural tube defects in
offspring provides evidence that maternal folate intake
is a key aetiological factor.
Limitations of mendelian randomisation
Clearly the approach has potential, but several
limitations need to be considered (box). Establishing
reliable associations between the genotype or interme-
diate phenotype and the disease is a particular concern
and is largely related to the limited sample size of cur-
rent studies.
This problem relates to all genetic association stud-
ies.13 A recent illustration of this is the association
between MTHFR genotype and coronary heart
disease. Since the MTHFR TT genotype is associated
with raised homocysteine concentrations, a meta-
analysis of studies that showed increased risk of disease
associated with this genotype was taken as strong
evidence of the causal nature of the association
between homocysteine and coronary heart disease14
and used to support a protective effect of folate, which
lowers homocysteine concentrations.15 Recently a large
study has shown that the strength of the association
(and thus the protective effect of folate) may have been
overestimated.16 An updated meta-analysis showed evi-
dence of potential publication bias (Begg test z = 2.06,
P = 0.039).
Although control of confounding is one of the
advantages of mendelian randomisation, it is essential
to show the relation of potential confounders to geno-
type to be sure that this is the case. Confounding may
arise either through multiple effects of a genotype
(pleiotropy) or through one genetic variant being
physically close to—and thus transmitted with—
another functional variant (linkage disequilibrium).
Most tests of such potential confounding have
suggested that it is either unappreciable or much less
than is observed in conventional epidemiology.
However, the possibility of such confounding should
be examined in all studies. For example, in the study we
discussed above of paroxanase variants and symptoms
of sheep dip toxicity, the relation between genotype
and symptom reporting among those unexposed to
sheep dip should be explored to test the assumption
that genotype is not related to differential symptom
reporting.
Another problem is developmental compensation.
If a person has developed and grown within an
environment in which one factor is perturbed because
of a particular genetic variant, they may be rendered
resistant to its influence through permanent changes
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Is sheep dip harmful? Turn to Mendelian randomisation
Uses and limitations of mendelian
randomisation in observational studies12
Uses
• Confounding—genetic variants will not generally be
liable to confounding by behavioural, socioeconomic,
and physiological factors
• Reverse causation—genetic variants will not be
influenced by the onset of disease or by the tendency
for individuals with disease to differentially report
exposure history
• Selection biases—genetic variants will not generally
be influenced by factors determining how participants
are selected into a study, either as a case or a control.
• Attenuation by errors (regression dilution
bias)—genetic variants will indicate differences in
exposure level across the lifetime and associations will
not be attenuated by random imprecision in
measurement of the exposure.
Limitations
• Cannot be used without a reliable association
between genotype and disease
• Confounding of genotype by linkage disequilibrium
between the genetic variant of interest and another
genetic variant that influences the outcome
• Genetic variants with multiple (pleiotropic) effects
may lead to misleading conclusions
• Canalisation and developmental stability
• Inadequate biological understanding of the function
of genetic variants
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in tissue structure and function that counterbalance its
effects—so called canalisation.7
Conclusion
Study of genetic variants can lead to inferences on how
population-wide changes in environmental exposures
could reduce risk of disease.17–20 Importantly, the infer-
ences are concerned with attribution of causality that is
relevant to whole populations and are not concerned
with targeting interventions on those with specific
genetic variants. By applying the increasing knowledge
of human genetics, it is possible to improve knowledge
of how diverse environmental exposures, many of
which are socially patterned, shape population health
and where future public health prevention should be
targeted.
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Summary points
Observational epidemiological studies have often
identified spurious apparent causes of disease
Confounding has probably contributed to many
of these misidentifications
Genetic variants that proxy for environmentally
modifiable risk factors are not subject to
confounding
Mendelian randomisation (use of genetic
variations as proxies for modifiable risk factors in
observational studies) is a powerful new strategy
in epidemiology
Trouble comes in twos
We recently admitted two cases of tuberculous meningitis to our
hospital within a week. Although this is an urban area, the
condition is by no means common here. Both patients presented
with confusion and a right sixth nerve palsy. One patient
recovered fully, but the other remains affected. We applied the
lessons we learnt from the first case to the second. The literature
on the condition has been read, re-read, and consolidated.
In the past year we have admitted two cases of wound botulism
to our hospital. Both occurred after “skin-popping” (injecting
heroin subcutaneously when intravenous access is no longer
easy). This rare condition has an annual incidence of 20 cases.1
In the first case we did make the diagnosis for some time, thus
missing an opportunity for prompt treatment with the antitoxin.
The second case presented at 7 am and was diagnosed and
treated by 2 pm. The doctors who made the diagnosis in the
second case remembered the first and made an instant diagnosis.
This enabled early administration of the antitoxin, which is
known to reduce mortality and morbidity particularly if given at
the onset of symptoms.2
Some years ago, I worked as a senior house officer in
accident and emergency. I remember thinking that patients’
diseases were like buses; you don’t see something for months,
then three cases come at once—a day of suturing right thumbs or
a day of cardioverting ventricular tachycardias. As the years
have passed such groupings seem to have changed. These days I
treat two pneumothoraces in a day or two patients with
tuberculosis. Sometimes I feel that someone somewhere is
hoping to educate us. See one, learn from it, and treat one
perhaps?
Anna Goodman respiratory registrar, Royal Berkshire Hospital,
Reading (anna.goodman@rbbh-tr.nhs.uk)
1 Health Protection Agency. Wound botulism cases in injecting drug users.
www.hpa.org.uk/infections/topics_az/botulism/Wound_Bot_Info.pdf
(accessed 17 Mar 2005).
2 Chang G, Ganguly G. Early antitoxin treatment in wound botulism results in
better outcome. Eur Neurol 2003;49:151-3.
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